Randomised phase III trial of radical chemo/radiotherapy vs radiotherapy alone in the definitive management of localised muscle invasive TCC of the urinary bladder
Primary Sponsor
Urological Society of Australasia
Collaborating Groups
Trans Tasman Radiation Oncology Group (TROG)
Final Accrual
67
Trial Chairperson
Dr Kumar Gogna, QRI Mater Centre, QLD
Trial Contact
Kumar Gogna
Clinical Trial Registration
Related Post
21 July, 2026
New TROG Scientific Committee Chair-Elect and members bring diverse experience
LATEST NEWS: 21 July 2026 The TROG Scientific Committee
16 July, 2026
TROG 08.03 RAVES sub-study sheds light on quality of life after post-prostatectomy radiotherapy
LATEST NEWS: 16 July 2026 Secondary analysis of data